Fundraising Fox

CureApp

2 known investors

CureApp develops evidence-based prescription therapeutic apps (software as a medical device / digital therapeutics) to treat conditions where conventional drugs or hardware devices fall short, delivering personalized follow-up and behavior change outside clinical visits. It also offers corporate mobile health programs for occupational health and workplace wellness.

Digital HealthHealthtechMedical Devices

Investors · 2

Beyond Next VenturesTokyo
Keio Innovation InitiativeTokyo · $1.5M – $64M

In the news

CureApp, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contactsbitscale.ai · Mar 2026Why We Invested in Japan’s 1st “Therapeutic App,” Founded By a Doctor | Beyond Next Venturesbeyondnextventures.com · Oct 2024Japanese digital therapeutics startup CureApp secures $51.5M in series G round – BRIDGEthebridge.jp · Aug 2022Carlyle to acquire significant minority stake in CureApp for JPY7bn - Private Equity Wireprivateequitywire.co.uk · Aug 2022CureApp gets funding treatment - Global Venturingglobalventuring.com · Mar 2021Japan’s medtech startup CureApp gets $14M to help reduce lifestyle diseases globallythebridge.jp · Feb 2018

Frequently asked questions

What does CureApp do?
CureApp develops evidence-based prescription therapeutic apps (software as a medical device / digital therapeutics) to treat conditions where conventional drugs or hardware devices fall short, delivering personalized follow-up and behavior change outside clinical visits. It also offers corporate mobile health programs for occupational health and workplace wellness.
Who are CureApp's investors?
CureApp's investors include Beyond Next Ventures, Keio Innovation Initiative.